Cargando…

Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer

BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, K, Mabuchi, S, Okazawa, M, Matsumoto, Y, Tsutsui, T, Fujita, M, Kamiura, S, Ogawa, K, Morrow, C P, Kimura, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619265/
https://www.ncbi.nlm.nih.gov/pubmed/23462721
http://dx.doi.org/10.1038/bjc.2013.78
_version_ 1782265483055071232
author Matsuo, K
Mabuchi, S
Okazawa, M
Matsumoto, Y
Tsutsui, T
Fujita, M
Kamiura, S
Ogawa, K
Morrow, C P
Kimura, T
author_facet Matsuo, K
Mabuchi, S
Okazawa, M
Matsumoto, Y
Tsutsui, T
Fujita, M
Kamiura, S
Ogawa, K
Morrow, C P
Kimura, T
author_sort Matsuo, K
collection PubMed
description BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors obtained from 540 radical hysterectomy specimens in stage IA2-IIB cervical cancer cases. Hazard ratio (HR) in each risk factor was determined, and the sum of HR scores for the corresponding risk factors was determined per case. Survival curves and postoperative treatment response (concurrent chemoradiotherapy (CCRT) vs radiotherapy alone) were evaluated based on the extent of HR-weighted scores. RESULTS: Hazard ratios for risk factors relating to disease-free survival (DFS) was: lympho-vascular space invasion 3.95, nodal metastasis 3.88, adenocarcinoma 3.40, large tumour 2.36, positive margin 1.99, deep stromal invasion 1.29, and parametria invasion 1.21. The HR-weighted scoring method showed a high predictive value for recurrence (area-under-curve 0.836, P<0.001). Hazard ratio-weighted scores were negatively correlated to DFS, and the cases with score ⩾12.5 showed 5-year DFS rate of 23.8%. Tumours with larger score offset the benefits of CCRT over radiotherapy alone for postoperative adjuvant treatment (P<0.001). CONCLUSION: Surgical–pathological risk factors provide valuable information for survival and management of early-stage cervical cancer when number and significance of risks are weighted.
format Online
Article
Text
id pubmed-3619265
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36192652014-04-02 Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer Matsuo, K Mabuchi, S Okazawa, M Matsumoto, Y Tsutsui, T Fujita, M Kamiura, S Ogawa, K Morrow, C P Kimura, T Br J Cancer Molecular Diagnostics BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors obtained from 540 radical hysterectomy specimens in stage IA2-IIB cervical cancer cases. Hazard ratio (HR) in each risk factor was determined, and the sum of HR scores for the corresponding risk factors was determined per case. Survival curves and postoperative treatment response (concurrent chemoradiotherapy (CCRT) vs radiotherapy alone) were evaluated based on the extent of HR-weighted scores. RESULTS: Hazard ratios for risk factors relating to disease-free survival (DFS) was: lympho-vascular space invasion 3.95, nodal metastasis 3.88, adenocarcinoma 3.40, large tumour 2.36, positive margin 1.99, deep stromal invasion 1.29, and parametria invasion 1.21. The HR-weighted scoring method showed a high predictive value for recurrence (area-under-curve 0.836, P<0.001). Hazard ratio-weighted scores were negatively correlated to DFS, and the cases with score ⩾12.5 showed 5-year DFS rate of 23.8%. Tumours with larger score offset the benefits of CCRT over radiotherapy alone for postoperative adjuvant treatment (P<0.001). CONCLUSION: Surgical–pathological risk factors provide valuable information for survival and management of early-stage cervical cancer when number and significance of risks are weighted. Nature Publishing Group 2013-04-02 2013-03-05 /pmc/articles/PMC3619265/ /pubmed/23462721 http://dx.doi.org/10.1038/bjc.2013.78 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Molecular Diagnostics
Matsuo, K
Mabuchi, S
Okazawa, M
Matsumoto, Y
Tsutsui, T
Fujita, M
Kamiura, S
Ogawa, K
Morrow, C P
Kimura, T
Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title_full Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title_fullStr Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title_full_unstemmed Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title_short Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
title_sort utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619265/
https://www.ncbi.nlm.nih.gov/pubmed/23462721
http://dx.doi.org/10.1038/bjc.2013.78
work_keys_str_mv AT matsuok utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT mabuchis utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT okazawam utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT matsumotoy utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT tsutsuit utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT fujitam utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT kamiuras utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT ogawak utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT morrowcp utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer
AT kimurat utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer